Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 24287463)

2.

The ribosomal S10 protein is a general target for decreased tigecycline susceptibility.

Beabout K, Hammerstrom TG, Perez AM, Magalhães BF, Prater AG, Clements TP, Arias CA, Saxer G, Shamoo Y.

Antimicrob Agents Chemother. 2015 Jun 29. pii: AAC.00547-15. [Epub ahead of print]

PMID:
26124155
3.

Successful use of tigecycline for treatment of culture-negative pyogenic vertebral osteomyelitis.

Seyman D, Berk H, Sepın-Ozen N, Kızılates F, Turk CC, Buyuktuna SA, Inan D.

Infect Dis (Lond). 2015 Jun 24:1-6. [Epub ahead of print]

PMID:
26107887
4.

Risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapy: A case-control study.

Park GE, Kang CI, Wi YM, Ko JH, Lee WJ, Lee JY, Cho SY, Ha YE, Chung DR, Peck KR, Song JH.

Antimicrob Agents Chemother. 2015 Jun 22. pii: AAC.04865-14. [Epub ahead of print]

PMID:
26100705
5.

[Vancomycin-resistant enterococci: increased mortality with tigecycline?].

Mutters NT, Mischnik A.

Dtsch Med Wochenschr. 2015 May;140(11):784. doi: 10.1055/s-0041-102303. Epub 2015 May 28. German. No abstract available.

PMID:
26080712
6.

Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004-2013.

Hoban DJ, Reinert RR, Bouchillon SK, Dowzicky MJ.

Ann Clin Microbiol Antimicrob. 2015 May 10;14:27. doi: 10.1186/s12941-015-0085-1.

7.

Fibrinogenopenia caused by tigecycline: a case report.

Zhang Q, Zhou J.

Eur Rev Med Pharmacol Sci. 2015;19(6):915-7. No abstract available.

8.
9.
10.

Rapid turbidimetric assay to potency evaluation of tigecycline in lyophilized powder.

da Silva LM, Salgado HR.

J Microbiol Methods. 2015 Mar;110:49-53. doi: 10.1016/j.mimet.2015.01.017. Epub 2015 Jan 22.

PMID:
25619746
11.

Five-year longitudinal assessment (2008 to 2012) of E-101 solution activity against clinical target and antimicrobial-resistant pathogens.

Denys GA, Pillar CM, Sahm DF, O'Hanley P, Stephens JT Jr.

Antimicrob Agents Chemother. 2014 Aug;58(8):4911-4. doi: 10.1128/AAC.03020-14. Epub 2014 May 19.

12.

In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.

Kanj SS, Whitelaw A, Dowzicky MJ.

Int J Antimicrob Agents. 2014 Feb;43(2):170-8. doi: 10.1016/j.ijantimicag.2013.10.011. Epub 2013 Nov 15.

PMID:
24315313
13.
14.

[An analysis of resistance of nosocomial infection pathogens isolated from 13 teaching hospitals in 2011].

Chen HB, Zhao CJ, Wang H, Cao B, Xu XL, Chu YZ, Hu ZD, Zhuo C, Hu BJ, Liu WE, Liao K, Zhang R, Zeng J, Wang Y, Luo YP, Wang ZW, Liu YM, Chen X, Tian B, Su DH, Zhou CM, Zou MX, Guo PH, Zhou HW, Jin Y.

Zhonghua Nei Ke Za Zhi. 2013 Mar;52(3):203-12. Chinese.

PMID:
23856111
15.
16.

Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010.

Balode A, Punda-Polić V, Dowzicky MJ.

Int J Antimicrob Agents. 2013 Jun;41(6):527-35. doi: 10.1016/j.ijantimicag.2013.02.022. Epub 2013 Apr 13.

PMID:
23590898
17.

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study.

Zhanel GG, Adam HJ, Baxter MR, Fuller J, Nichol KA, Denisuik AJ, Lagacé-Wiens PR, Walkty A, Karlowsky JA, Schweizer F, Hoban DJ; Canadian Antimicrobial Resistance Alliance.

J Antimicrob Chemother. 2013 May;68 Suppl 1:i7-22. doi: 10.1093/jac/dkt022.

18.

Epidemiology and susceptibility of Gram-negative appendicitis pathogens: SMART 2008-2010.

Lob SH, Badal RE, Bouchillon SK, Hawser SP, Hackel MA, Hoban DJ.

Surg Infect (Larchmt). 2013 Apr;14(2):203-8. doi: 10.1089/sur.2012.034. Epub 2013 Mar 29.

PMID:
23540793
19.

Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011).

Sader HS, Flamm RK, Jones RN.

Diagn Microbiol Infect Dis. 2013 Apr;75(4):417-22. doi: 10.1016/j.diagmicrobio.2013.01.001.

PMID:
23514757
20.

Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010.

Fernández-Canigia L, Dowzicky MJ.

Ann Clin Microbiol Antimicrob. 2012 Oct 22;11:29. doi: 10.1186/1476-0711-11-29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk